The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort

The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort

Background: Screening with fecal occult blood test reduces colorectal cancer (CRC) incidence and mortality, and is currently implemented in most countries. However, around 40% of screening colonoscopies are normal. Thus, strategies to avoid these colonoscopies are highly necessary. Adding other feca...

Full description

Bibliographic Details
Main Authors: Gonzalo Hijos-Mallada, Alberto Lué, Raul Velamazan, Nuria Saura, Carlos Abril, Marta Lorenzo, Mercedes Navarro, Eduardo Chueca, Samantha Arechavaleta, Fernando Gomollón, Ángel Lanas, Carlos Sostres
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Medicine
Subjects:
colorrectal cancer
screening
fecal occult blood
fecal calprotectin
fecal transferrin
fecal lactoferrin
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.665786/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.665786/full

Similar Items